Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Post by deccamanon Sep 16, 2014 5:52pm
244 Views
Post# 22941850

from canadian cancer

from canadian cancer brochure

Aura device

Health Canada has recently approved the Verisante Aura, which is a device that visually scans a mole or lesion to determine if it is cancerous. The Aura device is non-invasive. It uses Raman spectroscopy to analyze chemical reactions in the skin, providing immediate and accurate results. It can be used by health professionals to detect both melanoma and non-melanoma skin cancers. Cancer agencies and dermatologists are being encouraged to use Aura, but family doctors can purchase the device as well. It may not be available at all centres. The device could reduce the number of biopsies performed on lesions that turn out to be benign. It may also reduce wait times for surgery for skin cancer.


Bullboard Posts